课题基金 / 基金详情

The induction of donor-specific tolerance in experimental renal allo-transplantation

The induction of donor-specific tolerance in experimental renal allo-transplantation
实验性同种异体肾移植中供体特异性耐受的诱导
批准号:
11671059
负责人:
SHIMIZU Akira
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2002

项目摘要

项目成果

SHIMIZU Akira的其他基金

相似基金

相关文献

中文摘要
翻译
尽管目前临床器官移植的免疫抑制治疗已经提高了移植物的存活率,但长期给药的治疗相关并发症仍然是长期成功的主要限制因素。因此,诱导供者特异性移植耐受是临床器官移植的主要目标。然而,移植耐受的机制仍不完全清楚。(1)在耐受诱导方案中,我们研究了与耐受形成相关的移植肾内事件,并指出在耐受形成过程中,移植肾中同时存在T细胞无能和T细胞缺失。(2)在本方案中,我们研究了与耐受诱导失败相关的移植肾的特征,并指出,在耐受诱导方案中,不稳定的耐受诱导与介导免疫…的持续免疫激活有关。急性和/或慢性排斥反应中移植物实质细胞的更多破坏。(3)探讨了慢性排斥反应的发生发展过程,因为慢性排斥反应是移植肾晚期失败的主要原因,但其发病机制尚不清楚。病理上,慢性排斥反应的特点是进行性间质纤维化、肾小管萎缩、慢性移植物肾小球病变和慢性移植物动脉病变。PTCs和肾小管的持续性排斥反应和肌成纤维细胞的增殖是慢性排斥反应进行性间质纤维化的显著特征,可能是其发病机制中的关键事件。细胞和抗体介导的对肾小球和动脉内皮细胞的急性和持续性排斥反应是急性移植物肾小球疾病和急性动脉内膜炎以及进展为慢性移植物肾小球疾病和慢性移植物动脉病变的关键致病决定因素。我们认为,主动耐受诱导的几种策略在器官移植中非常重要,这种策略可以在不长期应用免疫抑制剂的情况下诱导对移植器官的特异性免疫无反应。在耐受诱导方案的治疗中,快速稳定的耐受诱导是长期稳定接受移植物所必需的。较少
英文摘要
Although current immunosuppressive therapy for clinical organ transplantation has improved allograft survival, treatment-related complications of chronic drug administration still remain a major limitation to long-term success. Therefore, the major goal of clinical organ transplantation is to induce donor-specific transplantation tolerance. However, the mechanism of transplantation tolerance is still incompletely understood. (1) We examined to clarify the intra-renal allograft events associated with the development of tolerance in the tolerance induction protocol, and we indicated that both T cell anergy and T cell deletion occurred in the renal allografts during the development of tolerance. (2) We examined the characterization of renal allografts associated with the failure of tolerance induction in this protocol, and we also indicated that, in tolerance induction protocols, unstable tolerance induction was associated with the persistent immunological activation that mediated immunol … More ogical destruction of graft parenchymal cells in acute and/or chronic rejection. (3) We examined the process of the development of chronic rejection, because the leading cause of late kidney allograft failure is chronic rejection, yet little is known about its pathogenesis. Pathologically, chronic rejection was characterized by progressive interstitial fibrosis, tubular atrophy, chronic allograft glomerulopathy, and chronic allograft arteriopathy. The persistent rejection directed at PTCs and tubules, and proliferation of myofibroblasts were prominent features in the progressive interstitial fibrosis in chronic rejection, and were probably key events in its pathogenesis. The acute and persistent cell- and antibody-mediated rejection against glomerular and arterial endothelial cells was key pathogenic determinant of acute allograft glomerulopathy and acute endarteritis as well as progression to chronic allograft glomerulopathy and chronic allograft arteriopathy.We conclude that several strategies of active tolerance induction, which can induce specific immunologic unresponsiveness to the transplanted organ without prolonged administration of immunosuppressive agents is important in the organ transplantation. In treatment with tolerant induction protocol, rapid and stable tolerance induction is necessary for long term stable graft acceptance. Less
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Shimizu A, Yamada K, Sachs DH, Colvin RB: "Mechanisms of chronic renal allograft rejection. I. Persistent rejection of peritubular capillaries and tubules is associated with progressive interstitial fibrosis"Kidney Int.. 61. 1867-1879 (2002)
Shimizu A、Yamada K、Sachs DH、Colvin RB:“慢性肾同种异体移植排斥的机制。I.肾小管周围毛细血管和肾小管的持续排斥与进行性间质纤维化有关”Kidney Int.. 61. 1867-1879 (2002)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Shimizu A, Yamada K, Meehan SM, Sachs DH, Colvin RB: "The acceptance reaction : Intragraft events associated with to lerance to renal allografts in miniature swine"Journal of American Society of Nephrology. 11. 2371-2380 (2000)
Shimizu A、Yamada K、Meehan SM、Sachs DH、Colvin RB:“接受反应:与小型猪肾同种异体移植耐受性相关的移植内事件”美国肾脏病学会杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Shimizu A, Yamada K, Sachs DH, Colvin RB: "Mechanisms of chronic renal allograft rejection. I. Persistent rejection of peritubular capillaries and tubules is associated with progressive interstitial fibrosis"Kidney International. (in press).
Shimizu A、Yamada K、Sachs DH、Colvin RB:“慢性肾同种异体移植排斥的机制。I.肾小管周围毛细血管和肾小管的持续排斥与进行性间质纤维化有关”肾脏国际。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Elevated type I interferon expression in dermatomyositis: involvement of LINE-1 and viral infection.
Statistical mechanics based on pure quantum states
  • 批准号:
    26287085
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $8.32万
  • 财政年份:
    2014
  • 负责人:
    SHIMIZU Akira
  • 依托单位:
A Study on Developing English, Chinese and Malay Teaching Materials Based on Communicating in Laboratories of Electronics
  • 批准号:
    26370690
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.58万
  • 财政年份:
    2014
  • 负责人:
    SHIMIZU Akira
  • 依托单位:
Immunological network in ANCA associated glomerulonephritis
  • 批准号:
    24591217
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.41万
  • 财政年份:
    2012
  • 负责人:
    SHIMIZU Akira
  • 依托单位:
国内基金
海外基金
PROCR信号通路介导的血管新生在卵巢组织移植中的作用及机制研究
  • 批准号:
    82371726
  • 项目类别:
    面上项目
  • 资助金额:
    50.00万元
  • 批准年份:
    2023
  • 负责人:
    李文
  • 依托单位:
骨髓抑制再生单个核细胞移植通过调节线粒体功能在脑缺血再灌注损伤中的神经保护机制研究
  • 批准号:
    82371301
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    李轶
  • 依托单位:
CD27-CD28-CD8+T细胞调控儿童肝脏移植免疫耐受形成的作用和机制
  • 批准号:
    82371791
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    刘永波
  • 依托单位:
肝脏类器官的建立及其在移植治疗肝脏疾病中的研究